| Application no. and date | 20739523.7 (espacenet) (Federated) (European Patent Register), 20200619 | | Patent/reg. no. and date | DK/EP 3989972, 20231108 | | Publication date | 20220504 | | Priority no. and date | US 201962868117 P, 20190628, US 201962904906 P, 20190924 | | EP pub. no. and date |
EP 3989972 20220504 | | Effective date | | | Applicant/owner | ELI LILLY AND COMPANY, Lilly Corporate Center
Indianapolis, IN 46206-6288, US | | Applicant ref. no. | V466383DK00 | | Inventor | QU, Fucheng, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US,
COATES, David Andrew, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
FIELDS, Todd, c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US,
HO, Joseph Daniel, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 3/10 (2006.01) , C07D 405/14 (2006.01) | | Title | Glucagon-lignende peptid-1-receptor-agonister | | Int. application no. | US2020038617 | | Int. publication no. | WO2020263695 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
